ReviewTherapeutics and clinical risk management2023

Practical Guidance for the Use of Patisiran in the Management of Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis.

Stacy Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.